phenylephrine has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Guo, T; Kan, X; Li, L; Wu, Y; Xiong, B; Zhang, Y; Zheng, C | 1 |
| Curley, SA; Dougherty, TB; Mikolajek, JA | 1 |
| Auer, KL; Dent, P; Fisher, PB; Gao, B; Kunos, G; Seth, P; Spector, MS; Tombes, RM | 1 |
1 trial(s) available for phenylephrine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Alfentanil; Anesthesia, Intravenous; Anesthetics, Intravenous; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Extracorporeal Circulation; Filtration; Hemodynamics; Hepatic Artery; Humans; Infusions, Intra-Arterial; Middle Aged; Monitoring, Physiologic; Phenylephrine; Propofol | 1997 |
2 other study(ies) available for phenylephrine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
Topics: Animals; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Diagnosis, Differential; Liver Neoplasms, Experimental; Male; Microbubbles; Microcirculation; Neoplasm, Residual; Perfusion Imaging; Phenylephrine; Phospholipids; Predictive Value of Tests; Rabbits; Regional Blood Flow; Sulfur Hexafluoride; Time Factors; Ultrasonography; Vasoconstrictor Agents | 2016 |
Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Carcinoma, Hepatocellular; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Epinephrine; Flavonoids; Humans; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Norepinephrine; Phenylephrine; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Thymidine; Transfection; Tumor Cells, Cultured | 1998 |